Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis

Clinical Research in Cardiology

Volumn 99, Issue 8, 2010, Pages 483-490

  Mereles, Derliz ^a   Buss, Sebastian J ^a   Hardt, Stefan E ^a   Hunstein, Werner ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Echocardiography; Epigallocatechin 3 gallate; Systemic light chain amyloidosis

Indexed keywords

DEXAMETHASONE; EPIGALLOCATECHIN GALLATE; MELPHALAN;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; IMMUNOGLOBULIN DEFICIENCY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SYSTEMIC IMMUNOGLOBULIN AMYLOID LIGHT CHAIN AMYLOIDOSIS; TEA;

AGED; AMYLOIDOSIS; CATECHIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; TEA; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955227051     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0142-x     Document Type: Article

References (31)

1. MA Gertz R Comenzo RH Falk, et al. 2005 Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004 Am J Hematol 79 319 328 10.1002/ajh.20381 16044444 (Pubitemid 41098849)
2. MA Gertz MG Lacy A Dispenzieri 2004 Therapy for immunoglobulin light chain amyloidosis: the new and the old Blood Rev 18 17 37 10.1016/S0268-960X(03) 00027-4 14684147 (Pubitemid 38200499)
3. E Roig L Almenar F González-Vílchez, et al. 2009 Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish registry for heart transplantation Am J Transplant 9 1414 1419 10.1111/j.1600-6143.2009.02643.x 1:STN:280:DC%2BD1Mrjs1SitQ%3D%3D 19459811
4. W Hunstein 2007 Epigallocatechin-3-gallate in AL amyloidosis: a new therapeutic option? Blood 110 2216 10.1182/blood-2007-05-089243 1:CAS:528:DC%2BD2sXhtVGjurzP 17785589 (Pubitemid 47443945)
5. MA Shammas P Neri H Koley, et al. 2006 Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications Blood 108 2804 2810 10.1182/blood-2006-05-022814 1:CAS:528:DC%2BD28XhtFWgtL3M 16809610
6. TD Shanafelt YK Lee TG Call, et al. 2006 Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies Leuk Res 30 707 712 10.1016/j.leukres.2005.10.020 1:STN:280:DC%2BD287nsVamtQ%3D%3D 16325256
7. TD Shanafelt TG Call CS Zent, et al. 2009 Phase I trial of daily oral polyphenon E in patients with asymptomatic Rai Stage 0 to II chronic lymphocytic leukemia J Clin Oncol 27 3808 3814 10.1200/JCO.2008.21.1284 1:CAS:528:DC%2BD1MXhtFaitrrM 19470922
8. K Rezai-Zadeh D Shytle N Sun, et al. 2005 Green tea epigallocatechin-3- gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J Neurosci 25 8807 8814 10.1523/JNEUROSCI.1521-05.2005 1:CAS:528:DC%2BD2MXhtVGls73F 16177050 (Pubitemid 41362059)
9. + exchangers Eur J Heart Fail 10 439 445 10.1016/j.ejheart.2008.03.004 1:CAS:528: DC%2BD1cXls1yqur8%3D 18406205
10. J Hao CH Kim TS Ha HY Ahn 2007 Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats J Vet Sci 8 121 129 10.4142/jvs.2007.8.2.121 17519564
11. DE Ehrnhoefer J Bieschke A Boeddrich, et al. 2008 EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat Struct Mol Biol 15 558 566 10.1038/nsmb.1437 1:CAS:528:DC%2BD1cXmslWgsbg%3D 18511942 (Pubitemid 351799141)
12. I Hauber H Hohenberg B Holstermann, et al. 2009 The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection Proc Natl Acad Sci USA 106 9033 9038 10.1073/pnas.0811827106 1:CAS:528:DC%2BD1MXntlyhurg%3D 19451623
13. D Mereles EE Wanker HA Katus 2008 Therapy effects of green tea in a patient with systemic light-chain amyloidosis Clin Res Cardiol 97 341 344 10.1007/s00392-008-0649-6 18317666
14. RM Lang M Bierig RB Devereux, et al. 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 1440 1463 10.1016/j.echo.2005.10.005 16376782 (Pubitemid 41821197)
15. SF Nagueh CP Appleton TC Gillebert, et al. 2009 Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 107 133 10.1016/j.echo.2008.11.023 19187853
16. PG Yock RL Popp 1984 Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation Circulation 70 657 662 1:STN:280:DyaL2M%2Fgt1ahtQ%3D%3D 6478568
17. SR Ommen RA Nishimura DG Hurrel, et al. 2000 Assessment of right atrial pressure with 2-dimensional and Doppler-echocardiography: a simultaneous catheterization and echocardiography study Mayo Clin Proc 75 24 29 10.4065/75.1.24 1:STN:280:DC%2BD3c%2FpsVCnuw%3D%3D 10630753
18. D Levy KM Anderson DD Savage, et al. 1988 Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study Ann Intern Med 108 7 13 1:STN:280:DyaL1c7gsFShtw%3D%3D 2962527
19. AG Siqueira-Filho CL Cunha AJ Tajik, et al. 1981 M-mode and two-dimensional echocardiographic features in cardiac amyloidosis Circulation 63 188 196 1:STN:280:DyaL3M%2FmsFWhtA%3D%3D 7438392
20. M Hongo S Ikeda 1986 Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy Circulation 73 249 256 1:STN:280:DyaL287gs1Knuw%3D%3D 3943160
21. AL Klein LK Hatle DJ Burstow, et al. 1990 Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis J Am Coll Cardiol 15 99 108 10.1016/0735-1097(90)90183-P 1:STN:280: DyaK3c7htVOlsg%3D%3D 2295749
22. AL Klein LK Hatle CP Taliercio, et al. 1990 Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis J Am Coll Cardiol 16 1135 1141 10.1016/0735-1097(90)90545-Z 1:STN:280:DyaK3M%2Fjs1Cruw%3D%3D 2229760
23. D Bellavia PA Pellikka TP Abraham, et al. 2008 Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography Am J Cardiol 101 1039 1045 10.1016/j.amjcard.2007.11.047 18359328
24. G Palladini F Lavatelli P Russo, et al. 2006 Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL Blood 107 3854 3858 10.1182/blood-2005-11-4385 1:CAS:528:DC%2BD28XkvFWhtbk%3D 16434487 (Pubitemid 43726787)
25. E Jantunen M Itälä T Lehtinen, et al. 2006 Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients Eur J Haematol 76 245 250 10.1111/j.1600-0609.2005.00605.x 1:STN:280:DC%2BD28%2Fmslaruw%3D%3D 16412136
26. IM Robertson MX Li BD Sykes 2009 The solution structure of human cardiac troponin C in complex with the green tea polyphenol; (-)-epigallocatechin-3- gallate J Biol Chem 284 23012 23023 10.1074/jbc.M109.021352 1:CAS:528: DC%2BD1MXpvFKiurs%3D 19542563
27. R Liao M Jain P Teller, et al. 2001 Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts Circulation 104 1594 1597 1:CAS:528:DC%2BD3MXotVehtrg%3D 11581134
28. R Sheng ZL Gu ML Xie, et al. 2009 EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy Planta Med 75 113 120 10.1055/s-0028-1088387 1:CAS:528:DC%2BD1MXisFGjtLY%3D 19096994
29. E Grünig B Janssen D Mereles, et al. 2000 Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene Circulation 102 1145 1150 10973844
30. SM Henning Y Niu Y Liu, et al. 2005 Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals J Nutr Biochem 16 610 616 10.1016/j.jnutbio.2005.03.003 1:CAS:528:DC%2BD2MXhtVegurzJ 16081270 (Pubitemid 41338373)
31. HH Chow IA Hakim DR Vining, et al. 2005 Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals Clin Cancer Res 11 4627 4633 10.1158/1078-0432.CCR-04-2549 1:CAS:528:DC%2BD2MXltFeksLY%3D 15958649 (Pubitemid 40825654)